BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17030802)

  • 1. Cell-free formation of misfolded prion protein with authentic prion infectivity.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15818-23. PubMed ID: 17030802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
    Piening N; Weber P; Giese A; Kretzschmar H
    Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of prion particle size on infectivity in vivo and in vitro.
    Weber P; Reznicek L; Mitteregger G; Kretzschmar H; Giese A
    Biochem Biophys Res Commun; 2008 May; 369(3):924-8. PubMed ID: 18328261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA molecules stimulate prion protein conversion.
    Deleault NR; Lucassen RW; Supattapone S
    Nature; 2003 Oct; 425(6959):717-20. PubMed ID: 14562104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
    Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
    Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
    Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
    Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
    Soto C; Estrada L; Castilla J
    Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of cell lines propagating infectious prions and the isolation and characterization of cell-derived exosomes.
    Vella LJ; Hill AF
    Methods Mol Biol; 2008; 459():69-82. PubMed ID: 18576148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment of a protein misfolding cyclic amplification for PrPSc].
    Han J; Han L; Shi Q; Shi S; Wang X; Zhang BY; Dong XP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):202-4. PubMed ID: 17971920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reconstitution of mammalian prion infectivity de novo.
    Baskakov IV
    FEBS J; 2007 Feb; 274(3):576-87. PubMed ID: 17288547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion formation, but not clearance, is supported by protein misfolding cyclic amplification.
    Shikiya RA; Eckland TE; Young AJ; Bartz JC
    Prion; 2014; 8(6):415-20. PubMed ID: 25482601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cells and prions: a license to replicate.
    Nuvolone M; Aguzzi A; Heikenwalder M
    FEBS Lett; 2009 Aug; 583(16):2674-84. PubMed ID: 19527722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the nature of prion diseases using cell-free assays.
    Lawson VA
    Methods Mol Biol; 2008; 459():97-103. PubMed ID: 18576150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion inactivation by the Maillard reaction.
    Suyama K; Yoshioka M; Akagawa M; Murayama Y; Horii H; Takata M; Yokoyama T; Mohri S
    Biochem Biophys Res Commun; 2007 Apr; 356(1):245-8. PubMed ID: 17336934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
    Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
    J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo generation of infectious prions in vitro produces a new disease phenotype.
    Barria MA; Mukherjee A; Gonzalez-Romero D; Morales R; Soto C
    PLoS Pathog; 2009 May; 5(5):e1000421. PubMed ID: 19436715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of prions in blood.
    Castilla J; Saá P; Soto C
    Nat Med; 2005 Sep; 11(9):982-5. PubMed ID: 16127436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of prion diseases.
    Unterberger U; Voigtländer T; Budka H
    Acta Neuropathol; 2005 Jan; 109(1):32-48. PubMed ID: 15645262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.